Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Long-Term Deferred Tax (2021 - 2025)

Quantum Biopharma's Long-Term Deferred Tax history spans 5 years, with the latest figure at $1.2 million for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax fell 98.86% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 98.86% decrease, with the full-year FY2025 number at $1.2 million, down 98.86% from a year prior.
  • Long-Term Deferred Tax hit $1.2 million in Q4 2025 for Quantum Biopharma, down from $109.1 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for QNTM hit a ceiling of $109.1 million in Q4 2024 and a floor of $1.2 million in Q4 2025.
  • Historically, Long-Term Deferred Tax has averaged $76.0 million across 5 years, with a median of $90.4 million in 2022.
  • Biggest five-year swings in Long-Term Deferred Tax: rose 16.94% in 2022 and later tumbled 98.86% in 2025.
  • Tracing QNTM's Long-Term Deferred Tax over 5 years: stood at $77.3 million in 2021, then rose by 16.94% to $90.4 million in 2022, then increased by 12.7% to $101.9 million in 2023, then increased by 7.03% to $109.1 million in 2024, then tumbled by 98.86% to $1.2 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for QNTM at $1.2 million in Q4 2025, $109.1 million in Q4 2024, and $101.9 million in Q4 2023.